VAERS Explorer
Back to explore

Report #2864392

Received Oct 8, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RVXROTAVIRUS (NO BRAND NAME)UNKNOWN MANUFACTURERUNKUNK—

Symptoms (1)

COVID-19

Symptom narrative

Virus; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of covid-19 in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced covid-19 (Verbatim: Virus). The outcome of the covid-19 was not reported. It was unknown if the reporter considered the covid-19 to be related to RSV vaccine. It was unknown if the company considered the covid-19 to be related to RSV vaccine. Additional Information: GSK receipt date: 09-SEP-2025 Every person the reporter knew who had taken the jabs had contracted the Virus. This case is linked with US2025AMR117505, reported by same reporter.; Sender's Comments: US-GSK-US2025AMR117505:same reporter/differnet patient